Founded
KANDO id: 377662

Corporate information

Registration country

Company type

Innate immune drug development company

Funding rounds

Series C EUR 33,000,000


( )
Participants: BB Biotech Ventures (co-led the round), existing investor Novartis Venture Fund (co-led the round), Sunstone Capital, Baxter Ventures, Amgen Ventures, EMBL Ventures, existing investors Fountain Healthcare Partners, Roche Venture Fund, Seroba


Profile Country
Novartis Services Inc (Novartis Venture Fund)


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials